🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, open-label, multi-center, active-controlled Phase 2 c...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-10
Trial ID
NCT07677891
Treatments Being Tested
The primary objective is to evaluate the safety and tolerability of a singl...
Status
Terminated
Location
Professor Nemanja Damjanov
Start Date
2008-12
Trial ID
NCT00787137
Treatments Being Tested
This is a Phase 2, therapeutic exploratory study designed to evaluate the s...
Status
Active Not Recruiting
Location
The Catholic University of KOREA, Bucheon St.Mary's Hostital
Start Date
2024-12-05
Trial ID
NCT06712615
The aim of this study was to evaluate the efficacy of PG102 at lowering lev...
Status
Completed
Location
Soeul National University Bundang Hospital
Start Date
2006-12
Trial ID
NCT01106703
Treatments Being Tested
Phase 2 Randomized Study of PG-102 vs Placebo and Semaglutide in Type 2 Dia...
Status
Not Yet Recruiting
Location
Emeritus Research
Start Date
2026-01
Trial ID
NCT07187856
Treatments Being Tested
This is a Phase 1, first-in-human (FIH), randomized, double-blind, placebo-...
Status
Completed
Location
Catholic University Seoul St.Mary Hospital,
Start Date
2024-03-04
Trial ID
NCT06309667
Treatments Being Tested
The goal of this Phase 1 study is to evaluate the safety and tolerability o...
Status
Recruiting
Location
Nucleus Network
Start Date
2025-12-30
Trial ID
NCT06891287
Treatments Being Tested